Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Working Knowledge
Business Research for Business Leaders
  • Browse All Articles
  • Popular Articles
  • Cold Call Podcasts
  • About Us
  • Leadership
  • Marketing
  • Finance
  • Management
  • Entrepreneurship
  • All Topics...
  • Topics
    • COVID-19
    • Entrepreneurship
    • Finance
    • Gender
    • Globalization
    • Leadership
    • Management
    • Negotiation
    • Social Enterprise
    • Strategy
  • Sections
    • Book
    • Cold Call Podcast
    • HBS Case
    • In Practice
    • Lessons from the Classroom
    • Op-Ed
    • Research & Ideas
    • Research Event
    • Sharpening Your Skills
    • What Do You Think?
    • Working Paper Summaries
  • Browse All
    • COVID-19 Business Impact Center
      COVID-19 Business Impact Center
      What Can Economics Say About Alzheimer's Disease?
      28 Sep 2020Working Paper Summaries

      What Can Economics Say About Alzheimer's Disease?

      by Amitabh Chandra, Courtney Coile, and Corina Mommaerts
      This essay discusses the role of market frictions and "missing medicines" in drug innovation and highlights how frameworks and toolkits of economists can help our understanding of the determinants and effects of Alzheimer's disease on health.
      LinkedIn
      Email

      Author Abstract

      Alzheimer’s disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD. While there is overlap with the economics of aging, the defining features of the "economics of Alzheimer’s disease" is an emphasis on cognitive decline, choice by cognitively impaired patients, and a host of issues where dynamic contracts between patients and caregivers are hard to enforce. The presence of cognitively challenged consumers also opens up new areas of study at the intersection of law and economics for it is not clear if firms will exploit these individuals or whether competitive forces will temper the behavior of firms. In addition, the issue of innovation--in prevention, delivery and medicines—is is amplified in the economics of AD, where there may be insufficient investments in basic science and where a fragmented insurance system (at least in the United States) discourages private investments in these innovations. We discuss the role of market frictions and "missing medicines" in drug innovation and highlight how frameworks and toolkits of economists can help in our understanding of the determinants and effects of AD on health.

      Paper Information

      • Full Working Paper Text
      • Working Paper Publication Date: August 2020
      • HBS Working Paper Number: NBER Working Paper Series, No. 27760
      • Faculty Unit(s): Technology and Operations Management
        Trending
          • 24 Feb 2021
          • Lessons from the Classroom

          What History's Biggest Wars Teach Us About Leading in Peace

          • 25 Feb 2019
          • Research & Ideas

          How Gender Stereotypes Kill a Woman’s Self-Confidence

          • 17 May 2017
          • Research & Ideas

          Minorities Who 'Whiten' Job Resumes Get More Interviews

          • 13 Jul 2020
          • Research & Ideas

          Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

          • 09 Feb 2021
          • Cold Call Podcast

          Developing Resilience on the Path to Becoming a CEO

      Amitabh Chandra
      Amitabh Chandra
      Henry and Allison McCance Professor of Business Administration
      Contact
      Send an email
      → More Articles
      Find Related Articles
      • Technological Innovation
      • Research
      • Consumer Behavior
      • Health
      • Pharmaceutical

      Sign up for our weekly newsletter

      Interested in improving your business? Learn about fresh research and ideas from Harvard Business School faculty.
      ǁ
      Campus Map
      Harvard Business School Working Knowledge
      Baker Library | Bloomberg Center
      Soldiers Field
      Boston, MA 02163
      Email: Editor-in-Chief
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College